#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metastatic malignant melanoma Waldenstrom's macroglobulinaemia refractory Immunodeficiency common variable Juvenile idiopathic arthritis Monogenic diabetes Enteritis Cholestatic pruritus Primary adrenal insufficiency Henoch-Schonlein purpura Aplastic anaemia Systemic candida Osteosarcoma metastatic Lymphangiosarcoma Osteosarcoma Cytomegalovirus infection More trials…

    Learn about Rare Diseases

    Rett syndrome – Life with Disease Atypical haemolytic uraemic syndrome Mucopolysaccharidosis I – Basic Information Adrenogenital syndrome – Basic Information Burkitt’s lymphoma – Basic Information Atypical teratoid/rhabdoid tumour of CNS Andersen-Tawil syndrome Angiosarcoma recurrent – Treatment Paraneoplastic neurological syndrome – Diagnostics Hereditary ataxia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    [18F]Fapi-74 Gt005 Ezetimibe Cemiplimab RLY-2608 Pancreas Powder Miglustat Calcium Carbonate Clobetasol Propionate YOHIMBINE HYDROCHLORIDE M-(18F)-Fluorobenzylguanidine Minzasolmin Ibrexafungerp Tadalafil Venlafaxine Rbl027.2 Cefepime Hydrochloride Arsenic Trioxide Calcium Chloride Nimodipine More therapies…

    Learn about Your Condition

    Type 1 diabetes mellitus Renal disorder Aplastic anaemia Mucopolysaccharidosis Cardiomyopathy Electronic cigarette user Diabetic gastroparesis Tertiary adrenal insufficiency Oedema peripheral Plasma cell myeloma recurrent Kidney transplant rejection Pleural mesothelioma Haemodynamic instability Viral myocarditis Piriformis syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effects of Dapagliflozin for Patients with Refractory Heart Failure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    Investigated Drugs:
    • Dapagliflozin
    Spain

  • Study on the Long-Term Safety of Futibatinib and Fulvestrant for Patients with Malignant Solid Tumors

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Futibatinib
    • Fulvestrant
    France Portugal Spain Sweden

  • Study on Sarilumab and Etanercept for Rheumatoid Arthritis in Patients Not Responding to csDMARD Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Etanercept
    • Sarilumab
    Belgium Germany Italy The Netherlands Portugal Spain

  • Study on Apremilast for Treating Oral Ulcers in Children with Behçet’s Disease

    Recruiting

    3 1
    Investigated Drugs:
    • Apremilast
    France Greece Italy Spain

  • Study on Safinamide and Rasagiline for Treating Fatigue in Parkinson’s Disease Patients on Stable Dopaminergic Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic fatigue syndrome
    • Parkinson’s disease
    Investigated Drugs:
    • Rasagiline
    • Safinamide
    Spain

  • Study of Lutetium (177Lu) Vipivotide Tetraxetan for Patients with High-Risk Prostate Cancer After Radiation and Hormone Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Lutetium (177Lu) Vipivotide Tetraxetan
    Poland
Previous Page
1 … 530 531 532 533 534 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!